EBR Systems, Inc. (EBRCZ) stock: key figures, P/E, revenue and dividend
Health Care · United States
EBR Systems, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.62 m USD |
| Gross profit | 490,000.00 USD |
| Operating income | -46.09 m USD |
| EBIT | -45.82 m USD |
| Net income | -48.76 m USD |
| Diluted EPS – continuing operations | -0.12 USD |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
More stocks
- RoyalTek Co Ltd (3306.TWO)
- Mevaco S.A (MEVA.AT)
- Master Style PCL (MASTER.BK)
- Korea Flange (010100.KS)
- CapForce Inc. (CFOR)
- Insight Molecular Diagnostics Inc. (IMDX)
- General Plastic Industrial Co Ltd (6128.TW)
- Marisa Lojas S.A (AMAR3.SA)
- Hwaseung Industries Co Ltd (006060.KS)
- Corbus Pharmaceuticals Holdings, Inc. (CRBP)
- Showbox Corp (086980.KQ)
- Haivision Systems Inc (HAI.TO)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.